IMMUCELL CORPORATION - COMMON STOCK
5.0000
01-May-24 15:59:23
15 minutes delayed
Stocks
+0.0900
+1.83%
Today's range
5.0000 - 5.1600
ISIN
N/A
Source
NASDAQ
-
ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021
09 Nov 2021 16:02:49 By Nasdaq GlobeNewswire
-
ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021
06 Oct 2021 06:30:00 By Nasdaq GlobeNewswire
-
Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team
14 Sep 2021 06:30:00 By Nasdaq GlobeNewswire
-
ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®
24 Aug 2021 06:30:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
12 Aug 2021 16:05:01 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021
05 Aug 2021 06:30:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021
07 Jul 2021 07:00:01 By Nasdaq GlobeNewswire
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
19 May 2021 12:00:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021
13 May 2021 16:05:02 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021
06 May 2021 13:41:06 By Nasdaq GlobeNewswire
-
ImmuCell Closes $4,250,000 Equity Financing
14 Apr 2021 17:15:42 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021
07 Apr 2021 08:00:01 By Nasdaq GlobeNewswire
-
22 Feb 2021 16:03:48 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020
16 Feb 2021 13:42:05 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020
07 Jan 2021 08:00:00 By Nasdaq GlobeNewswire